A major biotech investor just walked away from MoonLake after a rough year for the stock. Here's what that move signals-and what long-term investors should keep an eye on next.
NEW YORK, Nov. 17, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of aTyr Pharma, Inc. ( NASDAQ:ATYR ) , Marex Group PLC ( NASDAQ:MRX ) , Cepton, Inc. ...
NEW YORK, Nov. 17, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics ( "MoonLake" or the "Company" ) ( NASDAQ:MLTX ) of a class action securities lawsuit.
LOS ANGELES, Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
NEW YORK, Nov. 13, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics ( NASDAQ:MLTX ) between March 10, 2024 and September 29, 2025, both dates inclusive ( the "Class Period" ) , of the important ...